Distinguished in BRCA Positive Breast Cancer

Laura Cortesi

Reggio Nell'emilia, IT 
Distinguished in BRCA Positive Breast Cancer
Reggio Nell'emilia, IT 
OverviewLocationsClinical Research

Overview

Laura Cortesi practices in Reggio Nell'emilia, Italy. Ms. Cortesi is rated as a Distinguished expert by MediFind in the treatment of BRCA Positive Breast Cancer. Her top areas of expertise are Breast Cancer in Men, Breast Cancer, BRCA Positive Breast Cancer, Oophorectomy, and Salpingo-Oophorectomy.

Her clinical research consists of co-authoring 116 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of BRCA Positive Breast Cancer.

Gender
Female

Locations

Reggio Nell'emilia, 42122, Italy
Other Locations
Modena, Italy
Milan, Italy
Parma, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Elacestrant, Standard of Care
Study Phase: Phase 3
An International, Multicenter, Phase II, Randomized, Parallel-arm Trial Investigating the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment
An International, Multicenter, Phase II, Randomized, Parallel-arm Trial Investigating the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment
Enrollment Status: Terminated
Publish Date: October 05, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

116 Total Publications

DonnaRosa Project: Exploring Informal Communication Practices Among Breast Cancer Specialists.
DonnaRosa Project: Exploring Informal Communication Practices Among Breast Cancer Specialists.
Journal: Current oncology (Toronto, Ont.)
Published: November 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cortesi's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile